Eli Lilly is a great company with strong growth in weight-loss drugs, but recent price cuts negotiated by the Trump administration raise questions about its current valuation.
Source Post
The reel discusses Eli Lilly (LLY) as a great company, highlighting its recent $3.5 billion investment in a...
Jun 30, 2026
The reel discusses Eli Lilly (LLY) as a great company, highlighting its recent $3.5 billion investment in a new manufacturing facility and its strong growth in diabetes and weight-loss drugs. It notes that Donald Trump called it a great company at a rally, and the stock has risen 12% since then. However, it also points out that the Trump administration negotiated a deal for Eli Lilly to cut prices by almost 70%, raising the question of whether the stock is now too expensive.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.